Four IPOs are scheduled to price in the week ahead. Chronic disease biotech Structure Therapeutics (GPCR) leads the week’s deals. The company is headquartered in California with R&D operations in China. Also on the calendar is holdover Lead Real Estate (LRE) may price in the week ahead. Nano-cap NeurAxis (NRXS) may also price. Four deals priced this week TXO Energy Partners LP (TXO), the year’s first energy IPO. QuantaSing Group (QSG), Genelux (GNLX) and Brera Holdings (BREA) also priced. A … Continue reading “US Weekly IPO and SPAC Monitor: Structure Therapeutics, Lead Real Estate and NeurAxis”
US Weekly IPO and SPAC Monitor: TXO Energy, QuantaSing, Genelux and Brera FC
Four IPOs are scheduled to price in the week ahead. TXO Energy Partners LP (TXO) leads the week’s deals, the year’s first energy IPO. Chinese edtech QuantaSing Group (QSG) is due to price after being delayed. Solid tumor biotech Genelux (GNLX) and Italian amateur football club operator Brera Holdings (BREA) are expected. Holdovers Lucy Scientific Discovery (LSDI) and BullFrog AI Holdings (BFRG) may also price in the week ahead. Early-stage Canadian psychotropics company Lucy plans to raise $8 million at … Continue reading “US Weekly IPO and SPAC Monitor: TXO Energy, QuantaSing, Genelux and Brera FC”